2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$8.35-$0.10 (-1.23%)
Price as of Sep 11, 2026 7:30 PM EDT- $552.5MMarket Cap
- 9.17%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$8.35-$0.10 (-1.23%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.45 | ||
Change | -$0.26 (-2.99%) | ||
Open | $8.82 | ||
High | $8.91 | ||
Low | $8.37 | ||
Previous Close | $8.71 | ||
Volume | 908,447 | ||
30-Day Average Volume | 611,229 | ||
1-Week Change | -10.01% | ||
1-Month Change | -6.01% | ||
1-Year Change | 9.17% | ||
3-Year Change | -69.67% | ||
5-Year Change | -91.29% | ||
Fundamentals | |||
Shares Outstanding | 65.4M | ||
Total Assets | $675.1M | ||
Market Cap | $552.5M | ||
Enterprise Value | $458.7M | ||
Period: QTR TTM FY | |||
Revenue | $249.7M | ||
Net Income | $169.4M | ||
Free Cash Flow | -$48.5M | ||
EBIT | $169.6M | ||
EBITDA | $170.3M | ||
Net Working Capital | $569.7M | ||
EPS | $2.58 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | 3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue